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Saccharomonospora azurea SZMC 14600 is a member of the family Pseudonocardiaceae exclusively 
used for industrial scale production of primycin a large 36-membered non-polyene macrolide lactone 
antibiotic belonging to the polyketide class of natural products. Even though maximum antibiotic yield 
has been achieved by empirically optimized two-step fermentation process, little is known about the 
molecular components and mechanisms underlying the efficient antibiotic production. In order to iden-
tify differentially expressed proteins (DEPs) between the pre- and main-fermentation stages of primycin, 
comparative 2D-PAGE experiments were performed. In total, 98 DEP spots were reproducibly detected, 
out of which four spots were excised from gels, and identified through MALDI-TOF/TOF mass spectrom-
etry. Peptide mass fingerprint analysis revealed peptide matches to HicB antitoxin for the HicAB toxin-
antitoxin system (EHK86651), to a nucleoside diphosphate kinase regulator ((Ndk; EHK81899) and two 
other proteins with unknown function (EHK88946 and EHK86777).
Keywords: Differentially expressed proteins – HicB-family protein – primycin – Saccharomonospora 
azurea – two-dimensional protein gel electrophoresis
INTRODUCTION
As the problem of antimicrobial resistance becomes more widespread, the need for 
new anti-infective agents is more urgent than ever [20]. Actinomycetes are known as 
one of the most significant producers of pharmacologically important metabolites 
with over 10,000 bioactive compounds identified [1, 15]. Our previous study demon-
strated that Saccharomonospora azurea SZMC 14600 strain has an enhanced ability 
to produce primycin, a non-polyene macrolide lactone antibiotic [11). This heat sta-
ble, organic solvent soluble antibiotic complex (A1, A2 and C1) was first described 
by Vályi-Nagy et al. [18]. Primycin (primycin sulphate) is an active ingredient of 
Ebrimycin gel that has been successfully applied to prevent the bacterial infection of 
surface traumas and burned tissues. Comparative in vitro re-investigation of the effi-
cacy of primycin clearly demonstrated that the antibiotic possesses high activity 
against the most frequent Gram-positive pathogens including some multi-drug resist-
* Corresponding author; e-mail address: ilda@gamma.ttk.pte.hu
Primycin fermentation in Saccharomyces 425
Acta Biologica Hungarica 67, 2016
ant strains, without remarkable resistance development [8]. To get a deeper insight 
into the bioactive natural products metabolism of S. azurea SZMC 14600 whole-
genome sequencing was performed [5]. The genome project clearly demonstrated that 
S. azurea is a prolific source of structurally diverse secondary metabolites, however, 
the in silico information was not tied to products in the laboratory until now. In order 
to further support our structural genomic data, in this pilot study a proteomics 
approach was performed. Two-dimensional protein gel electrophoresis (2-DE) fol-
lowed by MALDI-TOF mass spectrometry supported by bioinformatics tools allowed 
in-depth-analysis for understanding complex biological process of microbial second-
ary metabolism [4]. Our preliminary comparative proteomic study of S. azurea culti-
vated sequentially in pre- and main-fermentation medium revealed considerable 
quantitative and qualitative differences in protein profiles. Among the differentially 
expressed and clearly detectable proteins a nucleoside diphosphate kinase regulator, 
one of the HicB-family proteins, and two proteins with unknown functions were 
identified.
MATERIALS AND METHODS
Saccharomonospora azurea SZMC 14600 freeze-dried stock cultures maintained at 
–80 °C in Luria broth (Sigma-Aldrich) with 20% glycerol were used to directly 
inoculate 50 mL of pre-fermentation medium (PF) containing 3% (w/v) soy flour; 
4.2% (w/v) water soluble starch; 0.36% (w/v) NaCl; 0.6% (w/v) CaCO3 and 0.5% 
(w/v) sun oil (pH 8). PF-culture was grown for 2 days at 37 °C in an orbital shaker at 
200 rpm. Thereafter 1 mL suspension of bacterial cells was used to inoculate 35 mL 
of main-fermentation medium (MF) containing 4% (w/v) soy flour; 4% (w/v) water 
soluble starch; 0.3% (w/v) NaCl; 0.5% (w/v) CaCO3; 0.6% (w/v) sun oil; 0.3% (w/v) 
stearic acid and 0.1% (w/v) KH2PO4 (pH 9.5). The submerged MF cultures were 
incubated for 5 days on a rotary shaker (200 rpm) at 28 °C.
Soluble proteins were extracted from 300 mg fresh weight of mycelia mats as 
described by Wang et al. [19]. Upon completion of the first dimension, samples con-
taining 250 µg of total protein were mixed with rehydration buffer. Isoelectric focus-
ing of rehydrated protein samples were performed on 7 cm IPG Strips (pH 3–11, 
Bio-Rad) at 250 V for 15 min (rapid voltage ramping), at 4000 V for 1 hour (linear 
voltage ramping), at 4000 V for 15 hours (rapid voltage ramping). Finally, in order to 
avoid potential artefacts and to prevent diffusion of focused proteins, a hold step was 
maintained at 500 V until the run was stopped. After focusing, the IPG strips were 
equilibrated in 6 M urea; 20% (v/v) glycerol; 2% (w/v) SDS; 0.05 M Tris-HCl (pH 
8.8), and 2% (w/v) DTT for 20 min. The second dimension protein separations were 
performed on 12.5% (w/v) sodium dodecyl sulphate-polyacrylamide (SDS-PAGE) 
gels, stained with Coomassie Brilliant Blue (Sigma-Aldrich). Gel images were cap-
tured by AlphaImager high performance gel documentation system (Protein Simple, 
Alpha Innotech Co. San Leandro, CA) and protein spots were quantified using 
Prodigy SameSpots 2D software-package (Xpedition version 1.0, Alpha Innotech) 
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according to the manufacturer’s instructions. The normalized volume intensity was 
used for comparison between groups. The spots whose normalized volume intensity 
was higher than 1.5 and lower than 0.5 with respect to the control (LB or EF) at the 
level of p < 0,05 were defined as differential expressed protein (DEP). Three inde-
pendent biological replicates were performed under each condition (cultivation on 
LB, EF and MF).
Four of the differentially expressed protein spots were excised from the gel and 
destained by washing three times for 10 min in 200 µL of 50% (v/v) acetonitrile solu-
tion containing 50 mM NH4HCO3. The disulphide bonds of cysteines were reduced 
by 50 µL of 20 mM dithiotreitol (DTT) in 100 mM NH4HCO3 for 1 h at 55 °C. The 
alkylation of the cysteine groups was carried out in 50 µL of 20 mM iodoacetamide 
solution. The gel pieces were dehydrated at room temperature by a Speed Vac 
Concentrator (Speed Vac Plus, SC100A, Savant) and proteins were in-gel-digested in 
10 µL of 40 µg/μL modified trypsin (Promega, Madison, WI) in Tris buffer (2.5 mM, 
pH 8.5) at 37 °C overnight [16]. The digestion reactions were stopped with 15 µL 
aqueous solution of acetonitrile and formic acid (49/50/1 v/v/v). 
Protein samples were analysed using a MALDI TOF/TOF MS (Bruker Daltonics). 
Proteins from MS/MS spectra were identified using ProteinScape 2.1 server utilizes 
the MASCOT PMF database search software (www.matrixscience.com., Matrix 
Science Ltd.) and Bruker BioTools 3.2 software (Bruker Daltonics) accessing the 
MSDB, Swiss-Prot and NCBI non-redundant protein databases. The search parame-
ters were set as follows. Two missed cleavages were allowed; carbamidomethyl was 
set as fixed and oxidized methionine as variable modification, monoisotopic peptide 
masses was set to 150 ppm. In parallel, to improve the coverage and confidence of 
identified peptides open reading frame database of S. azurea SZMC14600 was also 
applied. Virtual protein patterns corresponding to the genomic data were generated by 
JVirGel 2.0 software [10]. All experiments were performed in triplicate. 
RESULTS
Proteomics techniques based on two-dimensional gel electrophoresis are capable of 
simultaneously separating thousands of proteins from a single organism. Our com-
parative whole genome analysis of S. azurea SZMC14600 revealed 4554 potential 
protein coding genes, among them 209 (4.5%) were considered involved in the regu-
lation of secondary metabolism, transport and metabolic processes (unpublished 
data). The comparison of the protein profiles of S. azurea cells obtained from the 
sequential culturing process in LB, PF and MF media revealed on average 402 ± 23, 
422 ± 31 and 424 ± 33 detectable protein spots, respectively (Fig. 1). The finding that 
a vast majority of proteins were separated in the molecular mass range of 10–88 kDa 
and had a pI range of 4.0–7.0 is in good agreement with previously published data 
[17, 21]. Among the visualized proteins 77 ± 12% were consistently present on all 
gels, nevertheless changing culture media from LB to PF and subsequently from PF 
to MF revealed 39 and 43 newly appeared (up-regulated) protein spots, respectively 
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Fig. 1. Two-dimensional gel electrophoresis images of the total proteins from high primycin producer S. 
azurea SZMC 14,600 grown in: A) LB medium, B) Pre-fermentation medium (PF), C) Main-fermentation 
medium (MF). The presence of newly appeared protein spots, which were detectable in all gels are indi-
cated by small black dots (B, C). Individual peptide spots (C) are numbered accordingly: 1. HicB-family 
protein; 2. Nucleoside diphosphate kinase regulator; 3. and 4., unknown proteins
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(Fig. 1B, C). In this pilot study, four of the MF medium induced peptide spots 
(Fig. 1C), that may be involved in enhancing the production of primycin were excised 
and analysed using MALDI TOF mass spectrometry. The corresponding single 
charged monoisotopic peptide masses were searched against MSDB, Swiss-Prot and 
NCBInr databases and revealed significant homology with one of the HicB family 
proteins, a nucleoside diphosphate kinase (Ndk) regulator and two other unknown 
proteins (Table 1). The most exciting and unexpected finding was the appearance of 
a HicB protein (antitoxin for the HicAB toxin-antitoxin system) in parallel with the 
enhanced primycin synthesis during the second phase of fermentation process.
DISCUSSION
It is widely accepted that bacterial secondary metabolism usually starts in the station-
ary phase of cell growth (idiophase) when cells encounter adverse environmental 
conditions, as represented by depletion of essential nutrients or the presence of dif-
ferent stress stimuli. Genomics-based technologies, including whole genome 
sequencing, transcriptome, proteome, and metabolome profiling, together with in 
silico modelling and simulation, have become vital tools in the recently evolved 
industrial system biology [13].
Since the first description of plasmid encoded bacterial toxin-antitoxin (TA) sys-
tems [14], several chromosomally located TA systems have been studied, however, 
their biological functions are still under debate [6, 12]. Chromosomal TA systems are 
small genetic modules classified into five types depending on the nature and mode of 
action of the antitoxin [9]. Although type II TA systems are probably the most abun-
dant and the best described class of TA systems, little is known about the roles of 
HicAB protein homologs of Gram-positive bacteria [2, 7]. In type II class, the anti-
toxin is a small protein capable of blocking the toxin’s disruptive behaviour by direct 
protein binding or blocking the promoter region of the TA operon. Our finding that 
HicB antitoxin was detected exclusively in late stage of the antibiotic fermentation 
Table 1
List of the identified proteins corresponding to excised spots from 2-DE  
by MALDI TOF/TOF MS system
Spot’












EHK81899  46 16000 – 5.13  6.3±1.1  0.036
3 Unknown protein EHK88946  70 15933 – 6.80 13.8±0.8 <0.001
4 Unknown protein EHK86777 106 18065 – 8.19 14.3±0.7 <0.001
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process underscore the hypothesis that TA systems could play a role in secondary 
metabolite production activated by nutrient starvation or other forms of environmen-
tal stresses. 
Additionally, three differential protein spots were found related to the main-fer-
mentation step (Table 1). Spots 3 and 4 (Fig. 1B) represent predicted proteins with 
unknown functions, while the spot 2 corresponds with the nucleoside diphosphate 
kinase regulator protein. Ndk is a major housekeeping enzyme in the production of 
NTPs and dNTPs that are fundamental for DNA/RNA synthesis, cell division, mac-
romolecular metabolism and growth, thus Ndk is important in the regulation of sta-
tionary phase survival of the bacterial cells [3].
Taken together, according to our best knowledge, this is the first report which 
offers proteomic insight into the primycin fermentation process of S.  azurea SZMC 
14600.
As a first step to create an optimal workflow for large-scale experiments, methods 
of high-resolution protein separation and parameters for peptide mass fingerprinting 
identifies proteins were optimized. Our pilot study based on SDS-PAGE followed by 
MALDI-TOF mass spectrometry revealed significant differences in protein profiles 
between the two stages of primycin fermentation process, however, further studies are 
required to clarify the potential role of these proteins. 
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